EHRA Premium Access

Antiarrhythmic drugs in blanking period after catheter ablation of atrial fibrillation do not change effectiveness of the procedure but add clinical benefit

Congress Presentation

About the speaker

Doctor Olga Reynbakh

Montefiore Medical Center Albert Einstein College of Medicine, New York (United States of America)
0 follower

8 more presentations in this session

Combined risk factors of an impaired fasting glucose and pre-hypertension are related to new onset atrial fibrillation in a healthy Asian population without underlying disease: A nationwide cohort stu

Speaker: Doctor J. Park (Seoul, KR)


Patterns and predictors of anticoagulant prescribing for stroke prevention in patients with nonvalvular atrial fibrillation: results from the GARFIELD-AF registry

Speaker: Professor J. Camm (London, GB)


The long-term risk of atrial fibrillation and associated outcomes after carotid endarterectomy

Speaker: Professor F. Leyva (Birmingham, GB)


Systematic screening for atrial fibrillation in 65-year-olds with risk factors for stroke. Data from the ACE 1950 Study

Speaker: Doctor T. Berge (Oslo, NO)


Body fat distribution as risk factor of new-onset atrial fibrillation in The European Prospective Investigation Into Cancer and Nutrition in Norfolk Study

Speaker: Ms J. Neefs (Amsterdam, NL)


Access the full session

Rapid Fire session 8 - Atrial fibrillation and stroke prevention

Speakers: Doctor O. Reynbakh, Doctor J. Park, Professor J. Camm, Professor F. Leyva, Doctor T. Berge...

About the event



18 June - 21 June 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb